The effect of guggulipid and nimesulide on MPTP-induced mediators of neuroinflammation in rat astrocytoma cells, C6

Chemico-Biological Interactions

Volumn 200, Issue 2-3, 2012, Pages 73-83

  Niranjan, Rituraj ^a   Rajasekar, N ^a   Nath, Chandishwar ^a   Shukla, Rakesh ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Guggulipid and nimesulide; MPTP; Neuroinflammation; NF B activation; Rat astrocytoma cells (C6)

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CALCIUM ION; CYCLOOXYGENASE 2; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GUGGULSTERONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NIMESULIDE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; DOWN REGULATION; GENE TRANSLOCATION; GLIA CELL; IMMUNOCYTOCHEMISTRY; NERVOUS SYSTEM INFLAMMATION; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; WESTERN BLOTTING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ASTROCYTOMA; BASE SEQUENCE; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYTOKINES; DNA PRIMERS; INFLAMMATION MEDIATORS; NERVOUS SYSTEM; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT EXTRACTS; PLANT GUMS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONAMIDES; TRANSCRIPTION FACTOR CHOP;

RATTUS;

EID: 84870281028     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.08.008     Document Type: Article

References (57)

1. P. Teismann, M. Vila, D.K. Choi, K. Tieu, D.C. Wu, V. Jackson-Lewis, and S. Przedborski COX-2 and neurodegeneration in Parkinson's disease Ann. N. Y. Acad. Sci. 2003 1991 272 277
2. H. Yokoyama, H. Kuroiwa, R. Yano, and T. Araki Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease Neurol. Sci. 29 2008 293 301
3. M. Kohutnicka, E. Lewandowska, I. Kurkowska-Jastrzebska, A. Czlonkowski, and A. Czlonkowska Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Immunopharmacology 39 1998 167 180
4. T. Kawano, J. Anrather, P. Zhou, L. Park, G. Wang, K.A. Frys, A. Kunz, S. Cho, M. Orio, and C. Iadecola Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity Nat. Med. 12 2006 225 229
5. X. Hu, D. Zhang, H. Pang, W.M. Caudle, Y. Li, H. Gao, Y. Liu, L. Qian, B. Wilson, D.A. Di Monte, S.F. Ali, J. Zhang, M.L. Block, and J.S. Hong Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease J. Immunol. 181 2008 7194 7204
6. J.S. Schneider, and F.J. Denaro Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in cat and mouse brain J. Neuropathol. Exp. Neurol. 47 1988 452 458
7. P.L. McGeer, and E.G. McGeer Glial reactions in Parkinson's disease Mov. Disord. 23 2008 474 483
8. W. Zhang, and D. Stanimirovic Current and future therapeutic strategies to target inflammation in stroke Curr. Drug Targets Inflamm. Allergy 1 2002 151 166
9. S. Karunakaran, and V. Ravindranath Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice. implication in Parkinson's disease J. Neurochem. 109 2009 1791 1799
10. D.L. Carbone, J.A. Moreno, and R.B. Tjalkens Nuclear factor kappa-B mediates selective induction of neuronal nitric oxide synthase in astrocytes during low-level inflammatory stimulation with MPTP Brain Res. 1217 2008 1 9
11. R. Niranjan, P.K. Kamat, C. Nath, and R. Shukla Evaluation of guggulipid and nimesulide on production of inflammatory mediators and GFAP expression in LPS stimulated rat astrocytoma, cell line (C6) J. Ethnopharmacol. 127 2010 625 630
12. R. Niranjan, C. Nath, and R. Shukla Guggulipid and nimesulide differentially regulated inflammatory genes mRNA expressions via inhibition of NF-κB and CHOP activation in LPS-stimulated rat astrocytoma cells, C6 Cell. Mol. Neurobiol. 31 2011 755 764
13. Y. Muramatsu, R. Kurosaki, H. Watanabe, M. Michimata, M. Matsubara, Y. Imai, and T. Araki Expression of S-100 protein is related to neuronal damage in MPTP-treated mice Glia 42 2003 307 313
14. R. Pratap, R. Pal, S. Singh, G. Shankar, C. Nath, H.K. Singh, D. Raina, A.K. Srivastava, A.K. Rastogi, P.S.R. Murthy, S. Srivastava, O.P. Asthana, N. Singh, N. Anand, Method of treating a cognitive memory dysfunction using guggulipid, United State Patent 6 (2005) 896,901 B2.
15. G. Saxena, S.P. Singh, R. Pal, S. Singh, R. Pratap, and C. Nath Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice Pharmacol. Biochem. Behav. 86 2007 797 805
16. S. Shishodia, and B.B. Aggarwal Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis J. Biol. Chem. 279 2004 47148 47158
17. E. Candelario-Jalil, D. Alvarez, N. Merino, and O.S. León Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils Neurosci. Res. 47 2003 245 253
18. Y. Decker, G. McBean, and C. Godson Lipoxin A4 inhibits IL-1beta-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells Am. J. Physiol. Cell Physiol. 296 2009 1420 1427
19. R. Niranjan, C. Nath, and R. Shukla The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6 Free Radical Res. 44 2010 1304 1316
20. J. Martinez, T. Sanchez, and J.J. Moreno Regulation of prostaglandin E2 production by the superoxide radical and nitric oxide in mouse peritoneal macrophages Free Radical Res. 32 2000 303 311
21. M.I. Colado, E. O'Shea, R. Granados, A. Misra, T.K. Murray, and A.R. Green A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy Br. J. Pharmacol. 121 1997 827 833
22. M.E. Anderson, and R.A. Greenwald Handbook of Methods for Oxygen Radical Research 1985 CRC Press
23. 2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
24. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
25. S. Nogawa, F. Zhang, M.E. Ross, and C. Iadecola Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage J. Neurosci. 17 1997 2746 2755
26. C. Capitelli, and A. Sereniki Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats Eur. J. Pharmacol. 594 2008 101 108
27. K.A. Kelley, L. Ho, D. Winger, J. Freire-Moar, C.B. Borelli, P.S. Aisen, and G.M. Pasinetti Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2 Am. J. Pathol. 155 1999 995 1004
28. V.A. Tyurin, Y.Y. Tyurina, G.G. Borisenko, T.V. Sokolova, V.B. Ritov, P.J. Quinn, M. Rose, P. Kochanek, S.H. Graham, and V.E. Kagan Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates J. Neurochem. 75 2000 2178 2189
29. R.S. Akundi, E. Candelario-Jalil, S. Hess, M. Hull, K. Lieb, P.J. Gebicke-Haerter, and B.L. Fiebich Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia Glia 51 2005 199 208
30. D.A. Drechsel, and M. Patel Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease Free Radical Biol. Med. 44 2008 1873 1886
31. R.L. Miller, M. James-Kracke, G.Y. Sun, and A.Y. Sun Oxidative and inflammatory pathways in Parkinson's disease Neurochem. Res. 34 2009 55 65
32. R. Vijitruth, M. Liu, D.Y. Choi, X.V. Nguyen, R.L. Hunter, and G. Bing Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease J. Neuroinflammation 3 2006 6 8
33. J. Fukae, Y. Mizuno, and N. Hattori Mitochondrial dysfunction in Parkinson's disease Mitochondrion 7 2007 58 62
34. T. Iuvone, G. Esposito, D. Filippis De, T. Bisogno, S. Petrosino, C. Scuderi, V. Di Marzo, and L. Steardo Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro J. Mol. Med. (Berl) 85 2007 1379 1392
35. I. Bezprozvanny Calcium signaling and neurodegenerative diseases Trends Mol. Med. 15 2009 89 100
36. C.L. Parish, D.I. Finkelstein, W. Tripanichkul, A.R. Satoskar, J. Drago, and M.K. Horne The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice J. Neurosci. 22 2002 8034 8041
37. K.W. Hofmann, A.F. Schuh, J. Saute, R. Townsend, D. Fricke, R. Leke, D.O. Souza, L.V. Portela, M.L. Chaves, and C.R. Rieder Interleukin-6 serum levels in patients with Parkinson's disease Neurochem. Res. 34 2009 1401 1404
38. T. Muller, D. Blum-Degen, H. Przuntek, and W. Kuhn Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease Acta Neurol. Scand. 98 1998 142 144
39. M. Reale, C. Iarlori, A. Thomas, D. Gambi, B. Perfetti, M. Di Nicola, and M. Onofrj Peripheral cytokines profile in Parkinson's disease Brain Behav. Immun. 23 2009 55 63
40. C. Zhao, Z. Ling, M.B. Newman, A. Bhatia, and P.M. Carvey TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice Neurobiol. Dis. 26 2007 36 46
41. M.J. Bian, L.M. Li, M. Yu, J. Fei, and F. Huang Elevated interleukin-1beta induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine aggravating dopaminergic neurodegeneration in old male mice Brain Res. 1302 2009 256 264
42. E. Gilad, and H.R. Wong Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation FASEB J. 12 1998 685 693
43. M. Schmitt-Ney, and J.F. Habener CHOP/GADD153 gene expression response to cellular stresses inhibited by prior exposure to ultraviolet light wavelength band C (UVC) Inhibitory sequence mediating the UVC response localized to exon1 J. Biol. Chem. 275 2000 40839 40845
44. R.L. Davis, D.J. Buck, N. Saffarian, S. Mohan, U. DeSilva, S.C. Fernando, and C.W. Stevens Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells J. Neuroimmune Pharmacol. 3 2008 150 153
45. G.T. Liberatore, V. Jackson-Lewis, S. Vukosavic, A.S. Mandir, M. Vila, W.G. McAuliffe, V.L. Dawson, T.M. Dawson, and S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nat. Med. 5 1999 1403 1409
46. G. Oktem, S. Uslu, S.H. Vatansever, H. Aktug, M.E. Yurtseven, and A. Uysal Evaluation of the relationship between inducible nitric oxide synthase (iNOS) activity and effects of melatonin in experimental osteoporosis in the rat Surg. Radiol. Anat. 28 2006 157 162
47. G.S. Roh, C.O. Yi, Y.J. Cho, B.T. Jeon, I.T. Nizamudtinova, H.J. Kim, J.H. Kim, Y.M. Oh, J.W. Huh, J.H. Lee, Y.S. Hwang, S.D. Lee, and J.D. Lee Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 184 191
48. R. Sirianni, A. Chimento, A. De Luca, F. Zolea, A. Carpino, V. Rago, M. Maggiolini, S. Andò, and V. Pezzi Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells J. Biol. Chem. 284 2009 28905 28916
49. F.L. Avi, Smith A. Mark, Z. Xiongwei, T. Atsushi, N. Akihiko, M.I. Paula, and P. George Oxidative stress in Parkinson's disease Open Pathol. J. 3 2009 38 42
50. L.A. Videla, G. Tapia, R. Rodrigo, P. Pettinelli, D. Haim, C. Santibañez, A.V. Araya, G. Smok, A. Csendes, L. Gutierrez, J. Rojas, J. Castillo, O. Korn, F. Maluenda, J.C. Díaz, G. Rencoret, and J. Poniachik Liver NF-kappaB and AP-1 DNA binding in obese patients Obesity (Silver Spring) 17 2009 973 979
51. P.J. Hissin, and R.A. Hilf Fluorometric method for determination of oxidized and reduced glutathione in tissues Anal. Biochem. 74 1976 214 226
52. M. Tripathi, B.K. Singh, S. Raisuddin, and P. Kakkar Abrogation of nimesulide induced oxidative stress and mitochondria mediated apoptosis by Fumaria parviflora Lam, extract J. Ethnopharmacol. 136 2011 94 102
53. M. Naziroǧlu, C. Özgül, B. Çiǧ, S. Doǧan, and A.C. Uǧuz Glutathione modulates Ca(2+) influx and oxidative toxicity through TRPM2 channel in rat dorsal root ganglion neurons J. Membr. Biol. 242 2011 109 118
54. D.Y. Li, M.Y. Xue, Z.R. Geng, and P.Y. Chen The suppressive effects of Bursopentine (BP5) on oxidative stress and NF-κB activation in lipopolysaccharide-activated murine peritoneal macrophages Cell Physiol. Biochem. 29 2012 9 20
55. L.E. George, M.F. Lokhandwala, and M. Asghar Novel role of NF-κB-p65 in antioxidant homeostasis in human kidney-2 cells Am. J. Physiol. Renal Physiol. 302 2012 1440 14466
56. S. Gonzalo, L. Grasa, M.P. Arruebo, M.A. Plaza, and M.D. Murillo Inhibition of p38 MAPK improves intestinal disturbances and oxidative stress induced in a rabbit endotoxemia model Neurogastroenterol. Motil. 22 2010 564 572
57. L. Broom, L. Marinova-Mutafchieva, M. Sadeghian, J.B. Davis, A.D. Medhurst, and D.T. Dexter Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease Free Radical Biol. Med. 1 2011 633 640